News and Events

First patients enrolled in the Impulse Trial: A phase I dose-escalation study of high dose rate radiotherapy with electrons in patients with skin metastases from melanoma.

At Ohio State University, President Biden Introduced to the Future Potential of FLASH with Electrons Last week, U.S. President Joe Biden visited the Ohio State University James Comprehensive Cancer Center (OSUCCC) to discuss the latest innovations in cancer research. President Biden has committed his administration’s support to “end cancer as we know it” and is … Continued

IntraOp Medical Corporation and the University of Verona in Italy announced today the enrollment of the first patient in the PancFORT Trial: A phase II study of primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma.

New clinical technology and preclinical Flash radiotherapy in one platform to advance research and treatments for cancer patients

New Technology and Research has potential to transform the fundamentals of radiation oncology unlocking new opportunities for cancer patients.